| Date | Form | Description | Docs | XBRL | Pages |
| 04/11/18 | 144 | Filing for proposed sale of securities under Rule 144 |
|
2 | |
| 04/02/18 | 8-K | Current report filing |
|
4 | |
| 03/27/18 | 8-K | Current report filing |
|
48 | |
| 03/27/18 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
35 | |
| 03/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 03/05/18 | 8-K | Current report filing |
|
4 | |
| 02/15/18 | CT ORDER | Confidential treatment order |
|
1 | |
| 02/15/18 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
6 | |
| 02/14/18 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
37 | |
| 02/12/18 | DEF 14A | Definitive proxy statements |
|
36 |
Latest News & Events
Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Read More...Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...